In addition to clinical data, we found serum beta2 microglobulin as an independent predictor of AKI after ASCT and that for every increase in baseline β2M with 1 unit above 3.7 mg/L the risk for AKI increases by 3‐fold. Here, B2M is linked to acute kidney injury.